tenofovir alafenamide
An L-alanine derivative that is isopropyl L-alaninate in which one of the amino hydrogens is replaced by an (S)-({[(2R)-1-(6-amino-9H-purin-9-yl)propan-2-yl]oxy}methyl)(phenoxy)phosphoryl group. A prodrug for tenofovir, it is used (as the fumarate salt) in combination therapy for the treatment of HIV-1 infection.
Machine-generated and unreviewed. Identity, structure and cross-references come straight from ChEBI's and CARD's own data; no curator has signed off on this record yet.
Classification
Chemical structure
| Molecular formula | C21H29N6O5P |
|---|---|
| Charge | 0 |
| Average mass | 476.474 Da |
| Monoisotopic mass | 476.1937 Da |
| Source | ChEBI |
| InChIKey | LDEKQSIMHVQZJK-CAQYMETFSA-N |
CC(C)OC(=O)[C@H](C)N[P@](=O)(CO[C@H](C)Cn1cnc2c(N)ncnc21)Oc1ccccc1
InChI=1S/C21H29N6O5P/c1-14(2)31-21(28)16(4)26-33(29,32-17-8-6-5-7-9-17)13-30-15(3)10-27-12-25-18-19(22)23-11-24-20(18)27/h5-9,11-12,14-16H,10,13H2,1-4H3,(H,26,29)(H2,22,23,24)/t15-,16+,33+/m1/s1
Also called
- propan-2-yl N-[(S)-({[(2R)-1-(6-amino-9H-purin-9-yl)propan-2-yl]oxy}methyl)(phenoxy)phosphoryl]-L-alaninate
- GS 7340
- GS-7340
- TAF
Cross-references
- cas:379270-37-8
- reaxys:8948831
Drug registries
Patents and articles
Activity roles
- antiviral drug
CHEBI:36044 - HIV-1 reverse transcriptase inhibitor
CHEBI:53756
Source concepts
| Source | Native ID | Label | Minted CURIE | Version |
|---|---|---|---|---|
| CHEBI | CHEBI:90926 |
tenofovir alafenamide | antibioticmech:chebi-1c3df758b9 |
2026-08-30 |
Mechanism summary
- Mode of action
- VIRAL_POLYMERASE_INHIBITION microbial target
Curation history
-
SEEDED_FROM_SOURCES
Seeded from data/raw/ inventories (CHEBI)
-
RESEEDED_FROM_SOURCES
Re-seeded from updated data/raw/ inventories
-
RESEEDED_FROM_SOURCES
Re-seeded from updated data/raw/ inventories
-
RESEEDED_FROM_SOURCES
Re-seeded from updated data/raw/ inventories